Clinical Trial Update: World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial update focusing on post-COVID-19 rhinocerebral mucormycosis in Egypt.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucormycosis

Snippet

Sponsor: Nasser Institute For Research and Treatment | Conditions: Mucormycosis; Rhinocerebral (Etiology), COVID-19 | Phase 1, Phase 2 | Status: COMPLETED